Femasys Inc. Gains 346.32%
Tue, Sep 26, 2023 at 07:59 PM
Femasys Inc. (FEMY:NASDAQ) jumped higher at $1.48, representing a gain of 346.3%. On Tue, Sep 26, 2023, FEMY:NASDAQ touched a New 2-Week High of $1.48. The stock appeared on our News Catalysts scanner on Mon, Sep 25, 2023 at 07:40 PM in the 'BIOTECH' category. From Tue, Sep 12, 2023, the stock recorded 50.00% Up Days and 45.45% Green Days
About Femasys Inc. (FEMY:NASDAQ)
Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas.
Top 10 Gainers:
- Soleno Therapeutics, Inc. (SLNO:NASDAQ), 504.97%
- Femasys Inc. (FEMY:NASDAQ), 346.32%
- Signature Bank (SBNY:NASDAQ), 105.88%
- Immunovant, Inc. (IMVT:NASDAQ), 97.04%
- Digital Transformation Opportunities Corp. (DTOC:NASDAQ), 89.56%
- Intercept Pharmaceuticals, Inc. (ICPT:NASDAQ), 79.21%
- Republic First Bancorp, Inc. (FRBK:NASDAQ), 64.71%
- DMK Pharmaceuticals Corp Com Par $0.001 (DMK:NASDAQ), 59.25%
- Minerva Surgical Inc. (UTRS:NASDAQ), 55.22%
- Acasti Pharma Inc. (ACST:NASDAQ), 37.71%